Drug Information

Drug General Information
Drug ID
D03DXV
Former ID
DNC014087
Drug Name
4-(1,2,3-thiadiazol-4-yl)phenyl butylcarbamate
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529975]
Formula
C13H15N3O2S
Canonical SMILES
CCCCNC(=O)OC1=CC=C(C=C1)C2=CSN=N2
InChI
1S/C13H15N3O2S/c1-2-3-8-14-13(17)18-11-6-4-10(5-7-11)12-9-19-16-15-12/h4-7,9H,2-3,8H2,1H3,(H,14,17)
InChIKey
XVFSPFDRDOHQIV-UHFFFAOYSA-N
PubChem Compound ID
2739381
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529975]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529975Eur J Med Chem. 2009 Jul;44(7):2994-3008. Epub 2009 Jan 20.The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.
Ref 529975Eur J Med Chem. 2009 Jul;44(7):2994-3008. Epub 2009 Jan 20.The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.